Luye Pharma Group (HK:2186) has released an update. Luye Pharma Group has received approval from China’s National Medical ...

I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The global nanoparticle drug delivery systems market size is estimated to grow by USD 54.90 billion from 2024-2028, according ...

Luye Pharma Group (HK:2186) has released an update. Luye Pharma Group has announced a revised closing date for its issuance of $100 million convertible bonds, now set for October 30, 2024.

Sifting through countless of stocks in the Biotechnology industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...

The collaboration specifically targets GHGs from pharmaceutical packaging and single-use plastics. Credit: Mumemories/Shutterstock. Takeda and the Boston Medical Center (BMC) have announced a ...

Jakarta. US Ambassador to Indonesia, Kamala Shirin Lakhdhir, met with representatives from the US and Indonesian pharmaceutical companies on Tuesday to discuss the importance of healthcare services ...

It’s déjà vu for Marnius Pharmaceuticals. For the second time this year, the company’s seizure med Ztalmy missed in a phase 3 study, this time prompting it to cut off further development of ...

WASHINGTON - The Biden administration announced a new $20 billion loan to Ukraine which will be backed by the value of frozen Russian assets. The loan, known as the Extraordinary Revenue ...